The automated nucleic acid extraction devices market size has grown rapidly in recent years. It will grow from $6.6 billion in 2025 to $7.32 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to expansion of molecular diagnostic testing, rising prevalence of infectious diseases, increased laboratory automation adoption, growth of clinical testing volumes, advancements in nucleic acid chemistry.
The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $11.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, rising investments in genomic research, expansion of personalized medicine testing, growing adoption of point-of-care molecular diagnostics, technological improvements in extraction efficiency. Major trends in the forecast period include increasing adoption of fully automated extraction platforms, rising demand for high-throughput molecular diagnostics, growing use of integrated sample-to-result systems, expansion of automated lab workflows, enhanced focus on contamination-free processing.
The rising incidence of infectious diseases is anticipated to propel the growth of the automated nucleic acid extraction devices market in the future. Infectious diseases are disorders caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals or from animals to humans. The increase in infectious diseases, especially during global health crises like pandemics, amplifies the demand for diagnostic testing. Automated nucleic acid extraction devices are crucial for sample preparation in molecular diagnostics, aiding in the detection of viruses and bacteria. For example, in September 2023, GOV.UK, a UK-based public sector information site, reported a 7% rise in tuberculosis (TB) cases in England during the first half of 2023 compared to the same period in 2022, with notifications increasing from 2,251 to 2,408. Thus, the growing prevalence of infectious diseases is driving the expansion of the automated nucleic acid extraction devices market.
Major players within the automated nucleic acid extraction devices market are actively innovating by introducing automated nucleic acid extraction workstations to cater to a broader customer base, drive sales, and boost revenue. These workstations are specialized automated systems designed for extracting nucleic acids, such as DNA and RNA, from biological samples. For instance, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based in-vitro diagnostic products provider, introduced the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method) in April 2023. The SAW-48, an innovative in-vitro diagnostic medical device, integrates sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This system efficiently processes up to 48 samples concurrently, significantly reducing the time required to obtain test results. Its streamlined process benefits the detection of sexually transmitted diseases (STDs) and human papillomavirus (HPV), enhancing efficiency and speed in these diagnostic procedures.
In January 2023, ALS Limited, an Australia-based analytical and testing services company, acquired Invitek Molecular GmbH from Nuvisan GmbH. This strategic acquisition aims to expand ALS Limited's diagnostic capabilities and service offerings. Leveraging Invitek Molecular GmbH's technical expertise and experience in automated DNA/RNA extraction and nucleic acid purification solutions, ALS seeks to provide comprehensive diagnostic solutions to its clients, reinforcing its position as a one-stop-shop solution provider. Invitek Molecular GmbH, based in Germany, specializes in manufacturing automated solutions for DNA/RNA extraction and nucleic acid purification.
Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi'an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.
North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated nucleic acid extraction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the automated nucleic acid extraction devices market by increasing costs of imported instruments, reagents, consumables, and electronic components. Diagnostic laboratories and biotechnology companies in North America and Europe are most affected due to reliance on imported systems, while Asia-Pacific faces cost pressures on kit manufacturing and exports. These tariffs are increasing testing costs and delaying lab expansions. However, they are also encouraging local reagent production, regional manufacturing of devices, and innovation in cost-efficient diagnostic platforms.
The automated nucleic acid extraction devices market research report is one of a series of new reports that provides automated nucleic acid extraction devices market statistics, including automated nucleic acid extraction devices industry global market size, regional shares, competitors with a automated nucleic acid extraction devices market share, detailed automated nucleic acid extraction devices market segments, market trends and opportunities, and any further data you may need to thrive in the automated nucleic acid extraction devices industry. This automated nucleic acid extraction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated nucleic acid extraction devices are equipment used for major amplification processes such as isolation, purification, and concentration to detect specific pathogens in molecular diagnostic methods. These devices save time and labor compared to manually extracting nucleic acids from the same number of samples.
The main types of automated nucleic acid extraction devices include instruments, kits, and consumables. Instruments are measurement tools used by researchers and practitioners for the analysis and assessment of test and measurement equipment in various research and diagnostic applications. These devices, which are used in automated nucleic acid extraction, come in product types such as fully automated and semi-automated. End-users include hospitals, diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies, and academic research institutes.
The automated nucleic acid extraction devices market consists of sales of deoxyribonucleic acid (DNA) extraction kits, ribonucleic acid (RNA) extraction kits and protein extraction kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $11.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, rising investments in genomic research, expansion of personalized medicine testing, growing adoption of point-of-care molecular diagnostics, technological improvements in extraction efficiency. Major trends in the forecast period include increasing adoption of fully automated extraction platforms, rising demand for high-throughput molecular diagnostics, growing use of integrated sample-to-result systems, expansion of automated lab workflows, enhanced focus on contamination-free processing.
The rising incidence of infectious diseases is anticipated to propel the growth of the automated nucleic acid extraction devices market in the future. Infectious diseases are disorders caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals or from animals to humans. The increase in infectious diseases, especially during global health crises like pandemics, amplifies the demand for diagnostic testing. Automated nucleic acid extraction devices are crucial for sample preparation in molecular diagnostics, aiding in the detection of viruses and bacteria. For example, in September 2023, GOV.UK, a UK-based public sector information site, reported a 7% rise in tuberculosis (TB) cases in England during the first half of 2023 compared to the same period in 2022, with notifications increasing from 2,251 to 2,408. Thus, the growing prevalence of infectious diseases is driving the expansion of the automated nucleic acid extraction devices market.
Major players within the automated nucleic acid extraction devices market are actively innovating by introducing automated nucleic acid extraction workstations to cater to a broader customer base, drive sales, and boost revenue. These workstations are specialized automated systems designed for extracting nucleic acids, such as DNA and RNA, from biological samples. For instance, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based in-vitro diagnostic products provider, introduced the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method) in April 2023. The SAW-48, an innovative in-vitro diagnostic medical device, integrates sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This system efficiently processes up to 48 samples concurrently, significantly reducing the time required to obtain test results. Its streamlined process benefits the detection of sexually transmitted diseases (STDs) and human papillomavirus (HPV), enhancing efficiency and speed in these diagnostic procedures.
In January 2023, ALS Limited, an Australia-based analytical and testing services company, acquired Invitek Molecular GmbH from Nuvisan GmbH. This strategic acquisition aims to expand ALS Limited's diagnostic capabilities and service offerings. Leveraging Invitek Molecular GmbH's technical expertise and experience in automated DNA/RNA extraction and nucleic acid purification solutions, ALS seeks to provide comprehensive diagnostic solutions to its clients, reinforcing its position as a one-stop-shop solution provider. Invitek Molecular GmbH, based in Germany, specializes in manufacturing automated solutions for DNA/RNA extraction and nucleic acid purification.
Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi'an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.
North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated nucleic acid extraction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the automated nucleic acid extraction devices market by increasing costs of imported instruments, reagents, consumables, and electronic components. Diagnostic laboratories and biotechnology companies in North America and Europe are most affected due to reliance on imported systems, while Asia-Pacific faces cost pressures on kit manufacturing and exports. These tariffs are increasing testing costs and delaying lab expansions. However, they are also encouraging local reagent production, regional manufacturing of devices, and innovation in cost-efficient diagnostic platforms.
The automated nucleic acid extraction devices market research report is one of a series of new reports that provides automated nucleic acid extraction devices market statistics, including automated nucleic acid extraction devices industry global market size, regional shares, competitors with a automated nucleic acid extraction devices market share, detailed automated nucleic acid extraction devices market segments, market trends and opportunities, and any further data you may need to thrive in the automated nucleic acid extraction devices industry. This automated nucleic acid extraction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated nucleic acid extraction devices are equipment used for major amplification processes such as isolation, purification, and concentration to detect specific pathogens in molecular diagnostic methods. These devices save time and labor compared to manually extracting nucleic acids from the same number of samples.
The main types of automated nucleic acid extraction devices include instruments, kits, and consumables. Instruments are measurement tools used by researchers and practitioners for the analysis and assessment of test and measurement equipment in various research and diagnostic applications. These devices, which are used in automated nucleic acid extraction, come in product types such as fully automated and semi-automated. End-users include hospitals, diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies, and academic research institutes.
The automated nucleic acid extraction devices market consists of sales of deoxyribonucleic acid (DNA) extraction kits, ribonucleic acid (RNA) extraction kits and protein extraction kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automated Nucleic Acid Extraction Devices Market Characteristics
3. Automated Nucleic Acid Extraction Devices Market Supply Chain Analysis
4. Global Automated Nucleic Acid Extraction Devices Market Trends and Strategies
5. Automated Nucleic Acid Extraction Devices Market Analysis of End Use Industries
7. Global Automated Nucleic Acid Extraction Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automated Nucleic Acid Extraction Devices Total Addressable Market (TAM) Analysis for the Market
9. Automated Nucleic Acid Extraction Devices Market Segmentation
10. Automated Nucleic Acid Extraction Devices Market Regional and Country Analysis
11. Asia-Pacific Automated Nucleic Acid Extraction Devices Market
12. China Automated Nucleic Acid Extraction Devices Market
13. India Automated Nucleic Acid Extraction Devices Market
14. Japan Automated Nucleic Acid Extraction Devices Market
15. Australia Automated Nucleic Acid Extraction Devices Market
16. Indonesia Automated Nucleic Acid Extraction Devices Market
17. South Korea Automated Nucleic Acid Extraction Devices Market
18. Taiwan Automated Nucleic Acid Extraction Devices Market
19. South East Asia Automated Nucleic Acid Extraction Devices Market
20. Western Europe Automated Nucleic Acid Extraction Devices Market
21. UK Automated Nucleic Acid Extraction Devices Market
22. Germany Automated Nucleic Acid Extraction Devices Market
23. France Automated Nucleic Acid Extraction Devices Market
24. Italy Automated Nucleic Acid Extraction Devices Market
25. Spain Automated Nucleic Acid Extraction Devices Market
26. Eastern Europe Automated Nucleic Acid Extraction Devices Market
27. Russia Automated Nucleic Acid Extraction Devices Market
28. North America Automated Nucleic Acid Extraction Devices Market
29. USA Automated Nucleic Acid Extraction Devices Market
30. Canada Automated Nucleic Acid Extraction Devices Market
31. South America Automated Nucleic Acid Extraction Devices Market
32. Brazil Automated Nucleic Acid Extraction Devices Market
33. Middle East Automated Nucleic Acid Extraction Devices Market
34. Africa Automated Nucleic Acid Extraction Devices Market
36. Automated Nucleic Acid Extraction Devices Market Competitive Landscape and Company Profiles
37. Automated Nucleic Acid Extraction Devices Market Other Major and Innovative Companies
40. Automated Nucleic Acid Extraction Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Automated Nucleic Acid Extraction Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automated nucleic acid extraction devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automated nucleic acid extraction devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated nucleic acid extraction devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Instruments; Kits; Consumables2) By Automation Level: Fully Automated; Semi-Automated
3) By End User: Hospitals; Diagnostic Centers; Forensic Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes
Subsegments:
1) By Instruments: Automated Extractors; Liquid Handling Systems2) By Kits: DNA Extraction Kits; RNA Extraction Kits; Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents; Columns; Tips And Tubes
Companies Mentioned: QIAGEN N.V.; PerkinElmer Inc.; F. Hoffmann-La Roche AG; Analytik Jena GmbH; Thermo Fisher Scientific Inc.; Accubiomed Co. Ltd.; AutoGen Inc.; Bioneer Corporation; Tecan Group Ltd.; Merck KGaA; Becton Dickinson and Company; DiaSorin Molecular LLC; BioTeke Corporation (Wuxi) Co. Ltd.; Xi'an TianLong Science and Technology Co. Ltd.; Jiangsu Bioperfectus Technologies Co. Ltd.; Hangzhou Bloer Technology Co. Ltd.; MGI Tech Co. Ltd.; Aurora Biomed Inc.; Promega Corporation; Hamilton Company; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Zymo Research Corporation; Agilent Technologies Inc.; Danaher Corporation; Eppendorf AG; GE Healthcare Life Sciences; GenScript Biotech Corporation; Greiner Bio-One International GmbH; IntegenX Inc.; MicroGEM International Company; Norgen Biotek Corp.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automated Nucleic Acid Extraction Devices market report include:- QIAGEN N.V.
- PerkinElmer Inc.
- F. Hoffmann-La Roche AG
- Analytik Jena GmbH
- Thermo Fisher Scientific Inc.
- Accubiomed Co. Ltd.
- AutoGen Inc.
- Bioneer Corporation
- Tecan Group Ltd.
- Merck KGaA
- Becton Dickinson and Company
- DiaSorin Molecular LLC
- BioTeke Corporation (Wuxi) Co. Ltd.
- Xi'an TianLong Science and Technology Co. Ltd.
- Jiangsu Bioperfectus Technologies Co. Ltd.
- Hangzhou Bloer Technology Co. Ltd.
- MGI Tech Co. Ltd.
- Aurora Biomed Inc.
- Promega Corporation
- Hamilton Company
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Zymo Research Corporation
- Agilent Technologies Inc.
- Danaher Corporation
- Eppendorf AG
- GE Healthcare Life Sciences
- GenScript Biotech Corporation
- Greiner Bio-One International GmbH
- IntegenX Inc.
- MicroGEM International Company
- Norgen Biotek Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.32 Billion |
| Forecasted Market Value ( USD | $ 11.05 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
